Microstructure Characterization of Continuous-Discontinuous Fibre Reinforced Polymers based on Volumetric Images

Die quantitative Beschreibung der Mikrostruktur von Faserverbundwerkstoffen ist elementar für die Modellierung von thermischen und mechanischen Eigenschaften. Durch die stetige Entwicklung der Computertomographie ist es heute möglich dreidimensionale Bilddaten von Werkstoffen mit einer Auflösung von unter einem Mikrometer zu erzeugen. Moderne Computersysteme bieten ausreichend Rechenleistung um die resultierenden volumetrischen Bilddaten automatisiert auszuwerten und relevante Statistiken zu erzeugen. Die vorliegende Arbeit befasst sich mit der Quantifizierung von mikrostrukturellen Merkmalen von faserverstärkten Polymeren unter Verwendung von computertomographischen Aufnahmen. Diverse Verfahren zur Bestimmung von lokalen Faserorientierungen, -volumengehalt, -krümmungen und -längen wurden implementiert und validiert. Des Weiteren wurden zwei Ansätze zur Berechnung von lokalen Oberflächenkrümmungen zur Porositätsanalyse verglichen. Die Ergebnisse zeigen, dass einige der bereits verfügbaren Orientierungsanalyseverfahren bereits sehr robust sind und auch mit stark verrauschten Aufnahmen mit geringem Kontrast sehr gute Resultate erzielen. Faserlängenverteilungen, die mittels Fasertrackingverfahren aus computertomographischen Aufnahmen extrahiert wurden lieferten nur bis zu einer Probengröße von 5mm verlässliche Faserlängenverteilungen und sind daher nur bedingt für die Anwendung an langfaserverstärkten Polymeren geeignet

Route knowledge and configural knowledge in typical and atypical development: a comparison of sparse and rich environments

Background: Individuals with Down syndrome (DS) and individuals with Williams syndrome (WS) have poor navigation skills, which impact their potential to become independent. Two aspects of navigation were investigated in these groups, using virtual environments (VE): route knowledge (the ability to learn the way from A to B by following a fixed sequence of turns) and configural knowledge (knowledge of the spatial relationships between places within an environment). Methods: Typically developing (TD) children aged 5 to 11 years (N = 93), individuals with DS (N = 29) and individuals with WS (N = 20) were presented with a sparse and a rich VE grid maze. Within each maze, participants were asked to learn a route from A to B and a route from A to C before being asked to find a novel shortcut from B to C. Results: Performance was broadly similar across sparse and rich mazes. The majority of participants were able to learn novel routes, with poorest performance in the DS group, but the ability to find a shortcut, our measure of configural knowledge, was limited for all three groups. That is, 59 % TD participants successfully found a shortcut, compared to 10 % participants with DS and 35 % participants with WS. Differences in the underlying mechanisms associated with route knowledge and configural knowledge and in the developmental trajectories of performance across groups were observed. Only the TD participants walked a shorter distance in the last shortcut trial compared to the first, indicative of increased configural knowledge across trials. The DS group often used an alternative strategy to get from B to C, summing the two taught routes together. Conclusions: Our findings demonstrate impaired configural knowledge in DS and in WS, with the strongest deficit in DS. This suggests that these groups rely on a rigid route knowledge based method for navigating and as a result are likely to get lost easily. Route knowledge was also impaired in both DS and WS groups and was related to different underlying processes across all three groups. These are discussed with reference to limitations in attention and/or visuo-spatial processing in the atypical groups

miRNeye: a microRNA expression atlas of the mouse eye

<p>Abstract</p> <p>Background</p> <p>MicroRNAs (miRNAs) are key regulators of biological processes. To define miRNA function in the eye, it is essential to determine a high-resolution profile of their spatial and temporal distribution.</p> <p>Results</p> <p>In this report, we present the first comprehensive survey of miRNA expression in ocular tissues, using both microarray and RNA <it>in situ </it>hybridization (ISH) procedures. We initially determined the expression profiles of miRNAs in the retina, lens, cornea and retinal pigment epithelium of the adult mouse eye by microarray. Each tissue exhibited notably distinct miRNA enrichment patterns and cluster analysis identified groups of miRNAs that showed predominant expression in specific ocular tissues or combinations of them. Next, we performed RNA ISH for over 220 miRNAs, including those showing the highest expression levels by microarray, and generated a high-resolution expression atlas of miRNAs in the developing and adult wild-type mouse eye, which is accessible in the form of a publicly available web database. We found that 122 miRNAs displayed restricted expression domains in the eye at different developmental stages, with the majority of them expressed in one or more cell layers of the neural retina.</p> <p>Conclusions</p> <p>This analysis revealed miRNAs with differential expression in ocular tissues and provided a detailed atlas of their tissue-specific distribution during development of the murine eye. The combination of the two approaches offers a valuable resource to decipher the contributions of specific miRNAs and miRNA clusters to the development of distinct ocular structures.</p

Сверхлегкие генераторные модули для КВЧ-терапии

Разработаны миниатюрные генераторные модули для КВЧ-терапии, лег-ко фиксируемые в любом месте тела пациента. Могут быть использованы не только в медицине

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase&nbsp;1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation&nbsp;disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age&nbsp; 6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score&nbsp; 652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc&nbsp;= 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N&nbsp;= 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in&nbsp;Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in&nbsp;Asia&nbsp;and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Investigation of Quasi-Static and Dynamic Material Properties of a Structural Sheet Molding Compound Combined with Acoustic Emission Damage Analysis

Sheet molding compounds (SMC) are discontinuously fiber-reinforced thermosets, attractive to the automotive industry due to their outstanding specific strength and stiffness, combined with a cost efficient manufacturing process. Increasingly important for structural components, a structural SMC-based improved resin formulation featuring no fillers is investigated in this study. The influence of fiber volume content, fiber length, and manufacturing induced fiber orientation on quasi-static and dynamic mechanical properties of vinylester-based SMC is characterized. Stiffness and strength increased with increasing fiber volume content for tensile, compression, and flexural loadings. Fiber length distribution did not significantly influence the mechanical properties of the material. The movement of the conveyor belt leads to an anisotropic fiber orientation and orientation-dependent mechanical properties. Acoustic emission coupled with machine learning algorithms enabled the investigation of the damage mechanisms of this discontinuous glass fiber SMC. The acoustic emission analysis was validated with micro computed tomography of damaged specimens. The dominant failure mechanisms of the SMC exposed to bending loading were matrix cracking and interface failure